The effect of triamcinolone acetonide on laser-induced choroidal neovascularization in mice using a hypoxia visualization bio-imaging probe

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Takata, Shinsuke ^a   Masuda, Tomomi ^a   Nakamura, Shinsuke ^a   Kuchimaru, Takahiro ^b   Tsuruma, Kazuhiro ^a   Shimazawa, Masamitsu ^a   Nagasawa, Hideko ^c   Kizaka Kondoh, Shinae ^b   Hara, Hideaki ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^b TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^c Department of Organic and Medicinal Chemistry Pharmaceutical and Medicinal Chemistry   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; MOLECULAR PROBE; OXYGEN; RHODAMINE; TRIAMCINOLONE ACETONIDE;

ADVERSE EFFECTS; ANIMAL; C57BL MOUSE; CHOROIDAL NEOVASCULARIZATION; DISEASE MODEL; DRUG EFFECTS; ELECTRORETINOGRAPHY; HYPOXIA; LASER; MALE; METABOLISM; MOLECULAR PROBE; MOUSE; PATHOLOGY; PROCEDURES; PROTEIN DEGRADATION; PROTEIN TERTIARY STRUCTURE;

ANIMALS; CHOROIDAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; ELECTRORETINOGRAPHY; HYPOXIA; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LASERS; MALE; MICE; MICE, INBRED C57BL; MOLECULAR PROBES; OXYGEN; PROTEIN STRUCTURE, TERTIARY; PROTEOLYSIS; RHODAMINES; TRIAMCINOLONE ACETONIDE;

EID: 84946188877     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep09898     Document Type: Article

References (29)

1. Resnikoff, S. et al. Global data on visual impairment in the year 2002. Bull World Health Organ 82, 844-51 (2004).
2. Swaroop, A., Chew, E. Y., Rickman, C. B. & Abecasis, G. R. Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration. Annu Rev Genomics Hum Genet 10, 19-43 (2009).
3. Kwak, N., Okamoto, N., Wood, J. M. & Campochiaro, P. A. VEGF is major stimulator in model of choroidal neovascularization. Invest Ophthalmol Vis Sci 41, 3158-64 (2000).
4. Huang, L. E., Arany, Z., Livingston, D. M. & Bunn, H. F. Activation of hypoxiainducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J Biol Chem 271, 32253-9 (1996).
5. Kallio, P. J., Pongratz, I., Gradin, K., McGuire, J. & Poellinger, L. Activation of hypoxia-inducible factor 1alpha: posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor. Proc Natl Acad Sci USA 94, 5667-72 (1997).
6. Sheridan, C. M. et al. Expression of hypoxia-inducible factor-1alpha and-2alpha in human choroidal neovascular membranes. Graefes Arch Clin Exp Ophthalmol 247, 1361-7 (2009).
7. Sakurai, E., Anand, A., Ambati, B. K., van Rooijen, N. & Ambati, J. Macrophage depletion inhibits experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 44, 3578-85 (2003).
8. Yang, X. M. et al. Role of PI3K/Akt and MEK/ERK in mediating hypoxia-induced expression of HIF-1alpha and VEGF in laser-induced rat choroidal neovascularization. Invest Ophthalmol Vis Sci 50, 1873-9 (2009).
9. Rohrer, B. et al. A targeted inhibitor of the alternative complement pathway reduces angiogenesis in a mouse model of age-related macular degeneration. Invest Ophthalmol Vis Sci 50, 3056-64 (2009).
10. Gillies, M. C. et al. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial. Ophthalmology 113, 1533-8 (2006).
11. Jonas, J. B., Degenring, R. F., Kreissig, I., Friedemann, T. & Akkoyun, I. Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative nonrandomized study. Eye (Lond) 19, 163-70 (2005).
12. Krieglstein, T. R., Kampik, A. & Ulbig, M. Intravitreal triamcinolone and laser photocoagulation for retinal angiomatous proliferation. Br J Ophthalmol 90, 1357-60 (2006).
13. Krebs, I., Krepler, K., Stolba, U., Goll, A. & Binder, S. Retinal angiomatous proliferation: combined therapy of intravitreal triamcinolone acetonide and PDT versus PDT alone. Graefes Arch Clin Exp Ophthalmol 246, 237-43 (2008).
14. Criswell, M. H., Hu, W. Z., Steffens, T. J., Li, R. & Margaron, P. Comparing pegaptanib and triamcinolone efficacy in the rat choroidal neovascularization model. Arch Ophthalmol 126, 946-52 (2008).
15. Falkenstein, I. A. et al. Toxicity and intraocular properties of a novel long-acting anti-proliferative and anti-angiogenic compound IMS2186. Curr Eye Res 33, 599-609 (2008).
16. Kato, A. et al. Suppression of laser-induced choroidal neovascularization by posterior sub-tenon administration of triamcinolone acetonide. Retina 25, 503-9 (2005).
17. Hata, Y. et al. Vascular endothelial growth factor expression by hyalocytes and its regulation by glucocorticoid. Br J Ophthalmol 92, 1540-4 (2008).
18. Kuchimaru, T. et al. In vivo imaging of HIF-active tumors by an oxygendependent degradation protein probe with an interchangeable labeling system. PLoS One 5, e15736 (2010).
19. Biddie, S. C. et al. Transcription factor AP1 potentiates chromatin accessibility and glucocorticoid receptor binding. Mol Cell 43, 145-55 (2011).
20. Haller, J., Mikics, E. & Makara, G. B. The effects of non-genomic glucocorticoid mechanisms on bodily functions and the central neural system. A critical evaluation of findings. Front Neuroendocrinol 29, 273-91 (2008).
21. Ishibashi, T., Miki, K., Sorgente, N., Patterson, R. & Ryan, S. J. Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate. Arch Ophthalmol 103, 708-11 (1985).
22. Kunikata, H. et al. Intraocular concentrations of cytokines and chemokines in rhegmatogenous retinal detachment and the effect of intravitreal triamcinolone acetonide. Am J Ophthalmol 155, 1028-1037 e1 (2013).
23. Singhal, S., Lawrence, J. M., Salt, T. E., Khaw, P. T. & Limb, G. A. Triamcinolone attenuates macrophage/microglia accumulation associated with NMDA-induced RGC death and facilitates survival of Muller stem cell grafts. Exp Eye Res 90, 308-15 (2010).
24. Srinivas, V., Zhang, L. P., Zhu, X. H. & Caro, J. Characterization of an oxygen/redox-dependent degradation domain of hypoxia-inducible factor alpha (HIFalpha) proteins. Biochem Biophys Res Commun 260, 557-61 (1999).
25. Masson, N., Willam, C., Maxwell, P. H., Pugh, C. W. & Ratcliffe, P. J. Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation. Embo J 20, 5197-206 (2001).
26. Shen, W. et al. Effect of glucocorticoids on neuronal and vascular pathology in a transgenic model of selective Muller cell ablation. Glia 62, 1110-24 (2014).
27. Imai, S., Shimazawa, M., Nakanishi, T., Tsuruma, K. & Hara, H. Calpain inhibitor protects cells against light-induced retinal degeneration. J Pharmacol Exp Ther 335, 645-52 (2010).
28. Tsuruma, K., Tanaka, Y., Shimazawa, M., Mashima, Y. & Hara, H. Unoprostone reduces oxidative stress-and light-induced retinal cell death, and phagocytotic dysfunction, by activating BK channels. Mol Vis 17, 3556-65 (2011).
29. Inokuchi, Y. et al. Effect of an inducer of BiP, a molecular chaperone, on endoplasmic reticulum (ER) stress-induced retinal cell death. Invest Ophthalmol Vis Sci 50, 334-44 (2009).